Show simple item record

dc.contributor.authorNaiki, M.
dc.contributor.authorAsano, T.
dc.contributor.authorWaiyaki, P.G.,
dc.contributor.authorNoguchi, A.,
dc.contributor.authorMwangi, D.W.,
dc.contributor.authorMukuria, J.C
dc.date.accessioned2013-07-26T06:04:32Z
dc.date.available2013-07-26T06:04:32Z
dc.date.issued1995
dc.identifier.citationC, PROFMUKURIAJOSEPH. Mukuria, J.C 1995. ., . (1995). Evidence for a free N-acetylneuraminic acid . Biochemical Journal 305: 459 . : Plant Molecular Biology Reporter Vol. 27, pp. 79-85.en
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/51315
dc.description.abstractA preliminary short follow-up study of Hanganutziu and Deicher (HD) antibody titre and sialic acid levels in sera from 7 patients with hepatoma was carried out. Weekly HD antibody titres were abnormal in 6 patients with titres of 4 of the 6 falling to normal in some weeks. Sialic acids levels, however were abnormal (3.830-6.82mmol/ l) compared to those of 33 normal sera (1.08-2.73 mmol/1) throughout the 8 week screening period. There was a poor correlation between the antibody tires and the sialic acid levels (r<0.50) suggesting that at some stage of malignancy, the tumour was expressing N-glycolylneuraminic acid (Neu5Gc), the epitope of HD antigens as well as shedding into circulation, excess N-acetylneuraminic acid (Neu5Gc). Neu5Gc is a tumor-associated antigen. Measurement of antibodies to this epitope have shown that the antibodies have a potential of offering an alternative method of determining tumor growth and/or metastases. A major follow-up study incorporating information on cancer type, disease stage, therapy and the immnunological status of the patient is called for.en
dc.language.isoenen
dc.titleEvidence for a free N-acetylneuraminic aciden
dc.typeArticleen
local.publisherDepartment of Biochemistry, University of Nairobien


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record